H10: investigation summary d17 is selected under imdrf cause conclusion because the concluded cause is not adequately described by any other term for the machine not having a method for avoid performing the operation on out of the validated process ranges for temperature.Batch record review: lot 1j01511 was manufactured on 09/15/2021, in the surgical cover dressing (scd) line with a total of (b)(4) market units.Complaint investigator performed a batch record review on 03/10/2023, to verify if all the applicable procedures were followed system application product (sap) material identification 1257951 and manufacturing order (b)(4).As result no nonconformance was identified.Photo related to the reported problem is available for evaluation.Investigation conclusion: the purpose of this root cause investigation is the identify the probable cause for the complaint generated for surgical cover dressing (scd) 3 line due to ¿open seal (malfunction) scd¿.The applicable quality tests performed to these batches based on the process instructions (pi) for assembly and primary packaging - surgical cover dressing, obtained satisfactory results.All the components for assembly were correct per bill of materials (bom) and the machine parameters documented were also correct and documented in ¿anexo 1¿ of procedure instruction (pi).In addition, dimensional and seal test were performed with satisfactory results and documented in anexo 2 of procedure instruction (pi).No irregularities were found related to malfunction, nevertheless, as resulted on the section c) and d) is the probable cause of the issue since the equipment has no enabled alarms or others prevention systems for avoiding running the equipment with the validated parameters out of the process specification ranges as per procedure instruction (pi).-root cause (s).Method: the machine does not have a method for avoid performing the operation on out of the validated process ranges for temperature.This issue will be monitored through the post market product monitoring review process.To date no additional information has been received.Should additional information become available, a follow-up report will be submitted.Fda registration number reporting site: 1049092, manufacturing site: 9618003.
|